These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

946 related items for PubMed ID: 11148561

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L, Nini A, Bianchi M, Gandaglia G, Fossati N, Suardi N, Moschini M, Dell'Oglio P, Schiavina R, Montorsi F, Briganti A.
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [Abstract] [Full Text] [Related]

  • 3. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D, Loewen H, Roggenbuck U, Musch M, Klevecka V.
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
    Zincke H, Lau W, Bergstralh E, Blute ML.
    J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML.
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy.
    Kausik SJ, Blute ML, Sebo TJ, Leibovich BC, Bergstralh EJ, Slezak J, Zincke H.
    Cancer; 2002 Sep 15; 95(6):1215-9. PubMed ID: 12216087
    [Abstract] [Full Text] [Related]

  • 9. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA, Ward KC, Goodman M, Assikis V, Petros JA.
    Cancer; 2006 Jun 15; 106(12):2603-9. PubMed ID: 16700037
    [Abstract] [Full Text] [Related]

  • 10. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.
    Palapattu GS, Allaf ME, Trock BJ, Epstein JI, Walsh PC.
    J Urol; 2004 Nov 15; 172(5 Pt 1):1860-4. PubMed ID: 15540739
    [Abstract] [Full Text] [Related]

  • 11. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes.
    Mikel Hubanks J, Boorjian SA, Frank I, Gettman MT, Houston Thompson R, Rangel LJ, Bergstralh EJ, Jeffrey Karnes R.
    Urol Oncol; 2014 Jan 15; 32(1):26.e1-7. PubMed ID: 23395235
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of immediate androgen deprivation adjuvant therapy in patients with lymph node positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy].
    Miyamae K, Kitani K, Miyamoto K, Hamada S, Kawano T, Maehara A, Otsuka Y, Otsuka T, Hamada Y.
    Nihon Hinyokika Gakkai Zasshi; 2009 Jul 15; 100(5):570-5. PubMed ID: 19663244
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.
    BJU Int; 2011 Jun 15; 107(11):1748-54. PubMed ID: 20883488
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy.
    Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA.
    Eur Urol; 2014 Jan 15; 65(1):20-5. PubMed ID: 23619390
    [Abstract] [Full Text] [Related]

  • 18. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D, Goppelt M, Dorn R, Wawroschek F, Harzmann R.
    BJU Int; 2006 Jun 15; 97(6):1173-8. PubMed ID: 16686707
    [Abstract] [Full Text] [Related]

  • 19. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML.
    J Urol; 2005 Apr 15; 173(4):1121-5. PubMed ID: 15758719
    [Abstract] [Full Text] [Related]

  • 20. Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer.
    Tefilli MV, Gheiler EL, Tiguert R, Banerjee M, Sakr W, Grignon DJ, Pontes JE, Wood DP.
    J Urol; 1998 Sep 15; 160(3 Pt 1):802-6. PubMed ID: 9720552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.